Tower Research Capital LLC (TRC) - SENSEI BIOTHERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,807
-31.8%
7,259
-2.8%
0.00%
Q2 2023$8,516
+283766.7%
7,470
+282.1%
0.00%
Q1 2023$30.0%1,955
-7.3%
0.00%
Q4 2022$3
-100.0%
2,110
-56.4%
0.00%
Q3 2022$7,000
-30.0%
4,837
+10.4%
0.00%
Q2 2022$10,000
-9.1%
4,382
-7.8%
0.00%
Q1 2022$11,000
-47.6%
4,751
+31.1%
0.00%
Q4 2021$21,000
+162.5%
3,623
+367.5%
0.00%
Q3 2021$8,000
-42.9%
775
-45.0%
0.00%
Q2 2021$14,000
+75.0%
1,410
+147.4%
0.00%
Q1 2021$8,0005700.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Newtyn Management, LLC 1,800,000$1,350,1800.33%
Deuterium Capital Management, LLC 11,000$8,8000.02%
Duquesne Family Office 100,000$800.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 112,900$84,6860.00%
RAYMOND JAMES & ASSOCIATES 14,000$11,2000.00%
TWO SIGMA INVESTMENTS, LP 10,876$8,7010.00%
BANK OF AMERICA CORP /DE/ 90,774$72,6190.00%
WELLS FARGO & COMPANY/MN 132$1060.00%
NORTHERN TRUST CORP 26,049$20,8390.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders